Literature DB >> 32473317

Identifying adipogenic chemicals: Disparate effects in 3T3-L1, OP9 and primary mesenchymal multipotent cell models.

Faye V Andrews1, Stephanie M Kim1, Lariah Edwards1, Jennifer J Schlezinger2.   

Abstract

3T3-L1 pre-adipocytes are used commonly to identify new adipogens, but this cell line has been shown to produce variable results. Here, potential adipogenic chemicals (identified in the ToxCast dataset using the Toxicological Priority Index) were tested for their ability to induce adipocyte differentiation in 3T3-L1 cells, OP9 cells and primary mouse bone marrow multipotent stromal cells (BM-MSC). Ten of the 36 potential adipogens stimulated lipid accumulation in at least one model (novel: fenthion, quinoxyfen, prallethrin, allethrin, pyrimethanil, tebuconzaole, 2,4,6-tris (tert-butyl)phenol; known: fentin, pioglitazone, 3,3',5,5'-tetrabromobisphenol A). Only prallethrin and pioglitazone enhanced lipid accumulation in all models. OP9 cells were significantly more sensitive to chemicals known to activate PPARγ through RXR than the other models. Coordinate effects on adipocyte and osteoblast differentiation were investigated further in BM-MSCs. Lipid accumulation was correlated with the ability to stimulate expression of the PPARγ target gene, Plin1. Induction of lipid accumulation also was associated with reduction in alkaline phosphatase activity. Allethrin, prallethrin, and quinoxyfen strongly suppressed osteogenic gene expression. BM-MSCs were useful in coordinately investigating pro-adipogenic and anti-osteogenic effects. Overall, the results show that additional models should be used in conjunction with 3T3-L1 cells to identify a broader spectrum of adipogens and their coordinate effects on osteogenesis.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adipogen; Adipogenesis; Multipotent mesenchymal stromal cells; OP9, 3T3-L1; Osteogenesis; PPARγ; RXR; ToxPi

Mesh:

Substances:

Year:  2020        PMID: 32473317      PMCID: PMC9432570          DOI: 10.1016/j.tiv.2020.104904

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.685


  74 in total

1.  A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.

Authors:  Takao Fujimura; Chiaki Kimura; Tomoya Oe; Yoko Takata; Hiroyuki Sakuma; Ichiro Aramori; Seitaro Mutoh
Journal:  J Pharmacol Exp Ther       Date:  2006-05-08       Impact factor: 4.030

2.  A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis.

Authors:  M Gurnell; J M Wentworth; M Agostini; M Adams; T N Collingwood; C Provenzano; P O Browne; O Rajanayagam; T P Burris; J W Schwabe; M A Lazar; V K Chatterjee
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

3.  PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.

Authors:  N Kubota; Y Terauchi; H Miki; H Tamemoto; T Yamauchi; K Komeda; S Satoh; R Nakano; C Ishii; T Sugiyama; K Eto; Y Tsubamoto; A Okuno; K Murakami; H Sekihara; G Hasegawa; M Naito; Y Toyoshima; S Tanaka; K Shiota; T Kitamura; T Fujita; O Ezaki; S Aizawa; T Kadowaki
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

Review 4.  Concise review: stem cell antigen-1: expression, function, and enigma.

Authors:  Christina Holmes; William L Stanford
Journal:  Stem Cells       Date:  2007-03-22       Impact factor: 6.277

5.  Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients.

Authors:  Y Miyazaki; L Glass; C Triplitt; M Matsuda; K Cusi; A Mahankali; S Mahankali; L J Mandarino; R A DeFronzo
Journal:  Diabetologia       Date:  2001-12       Impact factor: 10.122

6.  Identical, similar or different? Learning about immunomodulatory function of mesenchymal stem cells isolated from various mouse tissues: bone marrow, spleen, thymus and aorta wall.

Authors:  Beáta Hegyi; Bernadett Sági; János Kovács; Judit Kiss; Veronika S Urbán; Gabriella Mészáros; Eva Monostori; Ferenc Uher
Journal:  Int Immunol       Date:  2010-05-23       Impact factor: 4.823

7.  Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.

Authors:  Weimin He; Yaacov Barak; Andrea Hevener; Peter Olson; Debbie Liao; Jamie Le; Michael Nelson; Estelita Ong; Jerrold M Olefsky; Ronald M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-05       Impact factor: 11.205

8.  The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARalpha-dependent mechanisms.

Authors:  Jérôme N Feige; Alan Gerber; Cristina Casals-Casas; Qian Yang; Carine Winkler; Elodie Bedu; Manuel Bueno; Laurent Gelman; Johan Auwerx; Frank J Gonzalez; Béatrice Desvergne
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

9.  Evaluation of a screening system for obesogenic compounds: screening of endocrine disrupting compounds and evaluation of the PPAR dependency of the effect.

Authors:  Anna Pereira-Fernandes; Heidi Demaegdt; Karine Vandermeiren; Tine L M Hectors; Philippe G Jorens; Ronny Blust; Caroline Vanparys
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

10.  Editor's Highlight: Screening ToxCast Prioritized Chemicals for PPARG Function in a Human Adipose-Derived Stem Cell Model of Adipogenesis.

Authors:  Briana Foley; Daniel L Doheny; Michael B Black; Salil N Pendse; Barbara A Wetmore; Rebecca A Clewell; Melvin E Andersen; Chad Deisenroth
Journal:  Toxicol Sci       Date:  2016-09-23       Impact factor: 4.849

View more
  7 in total

1.  Tributyltin protects against ovariectomy-induced trabecular bone loss in C57BL/6J mice with an attenuated effect in high fat fed mice.

Authors:  Rachel Freid; Amira I Hussein; Jennifer J Schlezinger
Journal:  Toxicol Appl Pharmacol       Date:  2021-10-05       Impact factor: 4.219

Review 2.  The new kids on the block: Emerging obesogens.

Authors:  Raquel Chamorro-Garcia; Almudena Veiga-Lopez
Journal:  Adv Pharmacol       Date:  2021-07-08

Review 3.  Obesity III: Obesogen assays: Limitations, strengths, and new directions.

Authors:  Christopher D Kassotis; Frederick S Vom Saal; Patrick J Babin; Dominique Lagadic-Gossmann; Helene Le Mentec; Bruce Blumberg; Nicole Mohajer; Antoine Legrand; Vesna Munic Kos; Corinne Martin-Chouly; Normand Podechard; Sophie Langouët; Charbel Touma; Robert Barouki; Min Ji Kim; Karine Audouze; Mahua Choudhury; Nitya Shree; Amita Bansal; Sarah Howard; Jerrold J Heindel
Journal:  Biochem Pharmacol       Date:  2022-04-05       Impact factor: 6.100

Review 4.  Obesogens: How They Are Identified and Molecular Mechanisms Underlying Their Action.

Authors:  Nicole Mohajer; Chrislyn Y Du; Christian Checkcinco; Bruce Blumberg
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-25       Impact factor: 5.555

5.  miR‑30a‑5p induces the adipogenic differentiation of bone marrow mesenchymal stem cells by targeting FAM13A/Wnt/β‑catenin signaling in aplastic anemia.

Authors:  Enbo Wang; Yunyan Zhang; Rongmei Ding; Xiaohua Wang; Shumin Zhang; Xinghua Li
Journal:  Mol Med Rep       Date:  2021-11-25       Impact factor: 2.952

Review 6.  On the Utility of ToxCast-Based Predictive Models to Evaluate Potential Metabolic Disruption by Environmental Chemicals.

Authors:  Dayne L Filer; Kate Hoffman; Robert M Sargis; Leonardo Trasande; Christopher D Kassotis
Journal:  Environ Health Perspect       Date:  2022-05-09       Impact factor: 11.035

7.  A Data-Driven Transcriptional Taxonomy of Adipogenic Chemicals to Identify White and Brite Adipogens.

Authors:  Stephanie Kim; Eric Reed; Stefano Monti; Jennifer J Schlezinger
Journal:  Environ Health Perspect       Date:  2021-07-29       Impact factor: 11.035

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.